Loading…
Loading…
Novo Nordisk (NYSE:NVO) stock is down 1% at $49.14, after the drugmaker filed a lawsuit against rival Eli Lilly (LLY), citing misleading advertising for its GLP-1 drugs.
As space becomes scarce, the company is experimenting with new store formats.
Popular (BPOP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fractyl Health Inc. (NASDAQ:GUTS) reported Wednesday one-year results from the Midpoint Cohort of its REMAIN-1 study, saying a single treatment with its investigational Revita DMR System helped patients maintain more of their GLP-1-induced weight loss than a sham procedure.
SpaceX became a publicly traded company on June 12 and now carries a roughly $2 trillion market cap. Some index ETFs added the stock within a few trading days of the IPO.
Shake Shack leverages a high-growth, urban-focused model with expanding international licensing and digital ordering platforms. Texas Roadhouse maintains a massive domestic footprint and strong net margins through a company-operated steakhouse strategy.
Shares of PepsiCo (NASDAQ:PEP | PEP Price Prediction) slipped after Wednesday's Q2 filing, opening today near $136.11 after closing at $142.51.
The social platform that Meta once positioned as a rival to Elon Musk's X now has 500 million users. It increasingly resembles Reddit.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for BPOP and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.